all report title image

MALARIA VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Malaria Vaccines Market, By Vaccine Type (Pre-Erythrocytic Vaccines, Erythrocytic Vaccines, and Multi-Antigen Vaccines), By Agent (Plasmodium Falciparum, Plasmodium Vivax, and Anopheles Species), By Age (Pediatric and Adult), By Distribution Channel (Public and Private), By End Users (Hospitals, Specialty Clinics, Community Health Centers, and Homecare), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In: 01 Apr, 2026
  • Code: CMI37
  • Page number: 166
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Malaria Vaccines Market, By Vaccine Type
      • Global Malaria Vaccines Market, By Agent
      • Global Malaria Vaccines Market, By Age
      • Global Malaria Vaccines Market, By Distribution Channel
      • Global Malaria Vaccines Market, By End Users
      • Global Malaria Vaccines Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Malaria Vaccines Market, By Vaccine Type, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pre-Erythrocytic Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Erythrocytic Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Multi-Antigen Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  5. Global Malaria Vaccines Market, By Agent, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Plasmodium Falciparum
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Plasmodium Vivax
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Anopheles Species
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  6. Global Malaria Vaccines Market, By Age, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  7. Global Malaria Vaccines Market, By Distribution Channel, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Public
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Private
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  8. Global Malaria Vaccines Market, By End Users, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Community Health Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Homecare
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  9. Global Malaria Vaccines Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Agent, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Agent, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Agent, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Agent, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Agent, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Agent, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End Users, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive Landscape

    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanaria Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Nobelpharma Co.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sumaya Biotech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GenVec
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bharat Biotech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Serum Institute of India
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novavax, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Inovio Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Vaxart, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • BioNTech SE
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Malaria Vaccines Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.